Enhancing Deep Sleep in Depression with Non-Invasive Brain Stimulation
Official title: Investigating Slow Wave Sleep Enhancement to Improve Cognitive Function in Adults With Depression
Run by Wake Forest University Health Sciences · NCT07143838 · Data updated 2026-11-12
This pilot test will try non-invasive brain stimulation during sleep to see if it increases deep sleep and improves mood and thinking in adults with major depressive disorder.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 40 Years to 80 Years |
| Sex | All |
| Enrollment | 12 (estimated) |
| Sponsor | Wake Forest University Health Sciences Academic / other |
| Locations | 1 site (Winston-Salem, North Carolina) |
| Status | Recruiting |
| Started | June 4, 2026 |
| Main results expected | March 2027 |
| Study ends | March 2027 |
| Registry record updated | June 29, 2026 |
| Trial ID | NCT07143838 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults with moderate depression who report cognitive complaints and can complete overnight sleep testing.
✕Probably not a fit
Individuals who do not show an increase in deep sleep or who have adverse reactions to stimulation may not experience benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This pilot study investigates whether transcranial electrical stimulation delivered during slow-wave sleep can boost deep sleep in adults with depression. EEG-based real-time sleep staging guides stimulation, applied as 0.5-1 mA for five 5-minute blocks with brief breaks. Participants wear an actigraphy device and complete cognitive and mood questionnaires to assess potential sleep, cognitive, and mood benefits. The study uses the Sleep WISP device to deliver stimulation and record data during overnight sessions at Wake Forest University Health Sciences. Outcomes will inform whether enhanced deep sleep translates to improved cognitive performance and mood symptoms in this population.
Why it matters
Potential benefit: If successful, participants may experience better deep sleep, which could be linked to improvements in mood and cognitive function.
How similar studies have gone: Prior work in healthy individuals suggested TES can enhance slow-wave sleep; this study extends testing to people with depression.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Ability to complete overnight sleep study including placement of EEG leads * Ability to read and understand English. * Moderate depression * Self-reported cognitive complaints Exclusion Criteria: * Previous adverse reaction to transcranial electrical stimulation * Presence of implanted devices (e.g. intracranial device, cochlear implant) * Presence of metal in head (e.g. surgical clip) * Sensitivity or allergy to silver * Presence of significant neurologic disease (e.g. Parkinson's disease, epilepsy/seizure disorder, severe migraine disorder) * History of significant head trauma * History of stroke or other ischemic event * Diagnosed with schizophrenia, bipolar disorder, substance use disorder, or presence of current suicidal ideation * Currently taking medications that could alter EEG or cognitive function * Presence of severe insomnia * Presence of severe, untreated sleep apnea * Currently pregnant * Planned travel outside time zone during the study
Where it's running
-
Wake Forest University Health Sciences
Winston-Salem, North Carolina, United States Recruiting
Study contacts
- Principal investigator: Ruth Benca, MD, PhD — Wake Forest University Health Sciences
- Study coordinator: Ruth Benca, MD, PhD
- Email: ruth.benca@advocatehealth.org
- Phone: 336-716-2911
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Understanding how the orbitofrontal cortex guides approach vs. avoidance in depression
This study tests how different parts of the orbitofrontal cortex influence whether people pursue rewards or risk loss, and whether this pattern is altered in Major Depressive Disorder.
-
Health education program to help depression in older adults and caregivers in Ho Chi Minh City
A community-based education program for people 60+ and their caregivers is being tested to see if it can lower depression and improve quality of life compared with standard care.
-
Prucalopride for low mood: testing a 5-HT4 receptor activator for cognition and sleep
This study tests whether prucalopride, a 5-HT4 receptor drug, can improve thinking and sleep in adults with low mood or major depressive disorder compared to a placebo.
-
Pre-visit Companion Brief: a primary care AI-assisted check for depression and anxiety
This pilot tests an AI-powered pre-visit assessment that creates a concise Companion Brief for clinicians to help identify depression and anxiety during routine primary care.
-
Medically tailored groceries to help depression in people with food insecurity
This trial tests whether giving medically tailored groceries for six months can reduce depressive symptoms in adults who have depression and struggle with access to food.
-
Health and Work Ability After Inpatient Treatment for Stress-Related Disorders: Follow-Up of the HARMODI Cohort
This study follows people who had inpatient treatment for stress-related disorders to see how their health and ability to work change over the next three years and what factors help them return to work.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.